NATCO Pharma Limited (NSE:NATCOPHARM)
816.55
+2.30 (0.28%)
Jan 28, 2026, 1:40 PM IST
NATCO Pharma Employees
NATCO Pharma had 4,199 employees as of March 31, 2025. The number of employees increased by 183 or 4.56% compared to the previous year.
Employees
4,199
Change (1Y)
183
Growth (1Y)
4.56%
Revenue / Employee
10.46M INR
Profits / Employee
3.66M INR
Market Cap
145.84B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,199 | 183 | 4.56% |
| Mar 31, 2024 | 4,016 | 70 | 1.77% |
| Mar 31, 2023 | 3,946 | -79 | -1.96% |
| Mar 31, 2022 | 4,025 | -1,021 | -20.23% |
| Mar 31, 2021 | 5,046 | 20 | 0.40% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alembic Pharmaceuticals | 16,571 |
| Ajanta Pharma | 9,628 |
| Emcure Pharmaceuticals | 6,731 |
| Piramal Pharma | 5,476 |
| Gland Pharma | 4,351 |
| Eris Lifesciences | 3,354 |
| Strides Pharma Science | 3,301 |
| Wockhardt | 2,296 |
NATCO Pharma News
- 1 day ago - Pharma sector stocks today, Jan 27: Syngene down 7%, Natco Pharma falls 2.31%, Alembic Pharma down 1% - Business Upturn
- 19 days ago - Pharma sector stocks today: Natco Pharma jumps 1.24%, Dr. Reddy’s Lab gain 0.32%, Divi’s Laboratories up 0.14% - Business Upturn
- 2 months ago - Natco Pharma shares rise over 4% as expansion strategy boosts investor sentiment - Business Upturn
- 2 months ago - NATCO Pharma concludes US FDA inspection at Chennai API unit, receives seven form 483 observations - Business Upturn
- 2 months ago - Natco Pharma Ltd (BOM:524816) Q2 2026 Earnings Call Highlights: Strategic Wins and Future ... - GuruFocus
- 2 months ago - Q2 2026 Natco Pharma Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - NATCO Pharma Q2 Results: Net profit drops 23% YoY to Rs 518 crore, revenue flat at Rs 1,363 crore - Business Upturn
- 3 months ago - NATCO Pharma launches Generic Everolimus Tablets 1mg in the U.S. market - Business Upturn